Literature DB >> 21947788

Pacemaker implantation in the extreme elderly.

Robert T Stevenson1, David Lugg, Robert Gray, Douglas Hollis, Michelle Stoner, Jeffrey L Williams.   

Abstract

INTRODUCTION: There are scant data for pacemaker implant complications and readmission rates in the extreme elderly (age ≥80 years) despite their common use in this population.
METHODS: This is a retrospective chart review of consecutive patients (n = 149, age ≥80 years) who underwent pacemaker implantation at a community hospital electrophysiology program from July 2008 through June 2010. Single-, dual-, and biventricular-chamber pacemakers and generator changes were included for analysis; cardioverter-defibrillator devices, temporary pacemakers, and loop recorders were excluded. Standard procedures for implantation were used. Major complications were defined as death, cardiac arrest, cardiac perforation, cardiac valve injury, coronary venous dissection, hemothorax, pneumothorax, transient ischemic attack, stroke, myocardial infarction, pericardial tamponade, and arteriovenous fistula. Minor complications were defined as drug reaction, conduction block, hematoma or lead dislodgement requiring reoperation, peripheral embolus, phlebitis, peripheral nerve injury, and device-related infection.
RESULTS: The overall mean age of implantation was 86 years. There were no intraprocedural complications. There was one major in-hospital complication (0.7%) and one minor in-hospital complication (0.7%). Within 30 days of implantation, there was an overall 5.4% rate of complications; four minor (2.7%) and four major (2.7%). There was a 30-day cardiovascular-attributable mortality of 0.7% and an all-cause mortality of 2%. There was a 5.4% rate of readmission within 30 days of implantation.
CONCLUSIONS: This report of pacemaker implantations in the extreme elderly reveals rates of implant complications comparable to data from younger patient populations while experiencing a higher 30-day all-cause mortality (that may be attributable to elevated all-cause mortality rates in this age group).

Entities:  

Mesh:

Year:  2011        PMID: 21947788     DOI: 10.1007/s10840-011-9618-5

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  25 in total

1.  Complications arising after implantation of DDD pacemakers: the MOST experience.

Authors:  Kenneth A Ellenbogen; Anne S Hellkamp; Bruce L Wilkoff; Jorge L Camunãs; John C Love; Tom A Hadjis; Kerry L Lee; Gervasio A Lamas
Journal:  Am J Cardiol       Date:  2003-09-15       Impact factor: 2.778

2.  Rib and sternum fractures in the elderly and extreme elderly following motor vehicle crashes.

Authors:  Vishal Bansal; Carol Conroy; David Chang; Gail T Tominaga; Raul Coimbra
Journal:  Accid Anal Prev       Date:  2010-11-12

3.  Health and disease in people over 85.

Authors:  Thomas Perls
Journal:  BMJ       Date:  2009-12-22

4.  Permanent Cardiac Pacing in Octogenarians.

Authors:  Shimon Rosenheck; Michael Geist; Alexey Weiss; Yonathan Hasin; Teddy A. Weiss; Mervyn S. Gotsman
Journal:  Am J Geriatr Cardiol       Date:  1995-11

5.  Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients.

Authors:  Peter Alter; Stefan Waldhans; Eveline Plachta; Rainer Moosdorf; Wolfram Grimm
Journal:  Pacing Clin Electrophysiol       Date:  2005-09       Impact factor: 1.976

6.  Long term complications in single and dual chamber pacing are influenced by surgical experience and patient morbidity.

Authors:  F Eberhardt; F Bode; H Bonnemeier; F Boguschewski; M Schlei; W Peters; U K H Wiegand
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

7.  Complications related to permanent pacemaker therapy.

Authors:  M S Kiviniemi; M A Pirnes; H J Eränen; R V Kettunen; J E Hartikainen
Journal:  Pacing Clin Electrophysiol       Date:  1999-05       Impact factor: 1.976

8.  Patient demographics, complications, and hospital utilization in 250 consecutive device implants in a new community hospital electrophysiology program--implications for 'niche' hospitals.

Authors:  Jeffrey L Williams; David Lugg; Robert Gray; Douglas Hollis; Michelle Stoner; Robert Stevenson
Journal:  Am Heart Hosp J       Date:  2010

9.  Is esophageal dysphagia in the extreme elderly (>or=80 years) different to dysphagia younger adults? A clinical motility service audit.

Authors:  J M Andrews; R J Fraser; R Heddle; G Hebbard; H Checklin
Journal:  Dis Esophagus       Date:  2008-05-02       Impact factor: 3.429

10.  Incidence and predictors of in-hospital events after first implantation of pacemakers.

Authors:  J W M van Eck; N M van Hemel; P Zuithof; J P M van Asseldonk; T L H M Voskuil; D E Grobbee; K G M Moons
Journal:  Europace       Date:  2007-06-07       Impact factor: 5.214

View more
  4 in total

1.  Rehospitalizations for complications and mortality following pacemaker implantation: A retrospective cohort study in an older population.

Authors:  Marianne H Gillam; Nicole L Pratt; Maria C S Inacio; Sepehr Shakib; Prashanthan Sanders; Dennis H Lau; Elizabeth E Roughead
Journal:  Clin Cardiol       Date:  2018-10-19       Impact factor: 2.882

2.  Pacemaker Implantation in Elderly Patients: Safety of Various Regimens of Anticoagulant Therapy.

Authors:  Denis Terekhov; Valeriy Agapov; Kirill Kulikov; Svetlana Zadorozhnaya; Vasiliy Samitin; Vladimir Maslyakov
Journal:  J Atr Fibrillation       Date:  2017-02-28

3.  Risk of conduction disturbances following different transcatheter aortic valve prostheses: the role of aortic valve calcifications.

Authors:  Francesco Pollari; Ferdinand Vogt; Irena Großmann; Jill Marianowicz; Marie Claes; Steffen Pfeiffer; Johannes Schwab; Theodor Fischlein
Journal:  J Geriatr Cardiol       Date:  2022-03-28       Impact factor: 3.327

4.  Pacemaker implantation complication rates in elderly and young patients.

Authors:  Kazım Serhan Ozcan; Damirbek Osmonov; Servet Altay; Cevdet Dönmez; Ersin Yıldırım; Ceyhan Türkkan; Barış Güngör; Ahmet Ekmekçi; Ahmet Taha Alper; Kadir Gürkan; Izzet Erdinler
Journal:  Clin Interv Aging       Date:  2013-08-07       Impact factor: 4.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.